[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350738-105":59,"doc-detail-350738-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunological-determinants-of-oncogenic-virus-driven-cancers-in-africa-mechanisms-co-infections-and-public-health-challenges","Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa - Mechanisms, Co-Infections and Public Health Challenges","","Oncogenic viruses contribute to about 20% of human cancers globally, with an outsized impact in Sub-Saharan Africa. This review synthesizes immunological mechanisms of viral carcinogenesis across the region, highlighting defective viral clearance, chronic immune activation, and immune evasion driven by co-infections, host genetic diversity, and environmental exposures. It details roles of HIV-associated CD4+ depletion, malaria, helminths, and tuberculosis in viral persistence. It also addresses HLA/cytokine polymorphisms, tumor immunosuppression, and gaps in vaccination, screening, and diagnostics shaping infection-linked cancer burden. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunological-determinants-of-oncogenic-virus-driven-cancers-in-africa-mechanisms-co-infections-and-public-health-challenges/350738/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunological-determinants-of-oncogenic-virus-driven-cancers-in-africa-mechanisms-co-infections-and-public-health-challenges/350738.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which oncogenic viruses are emphasized in the review’s scope for Africa-related cancers?","Question",{"text":112,"@type":113},"The review focuses on HPV, HBV, HCV, EBV, KSHV, and HTLV-1 as key oncogenic viruses contributing to cancer burden in Sub-Saharan Africa.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do co-infections and immune interactions contribute to viral persistence and cancer development?",{"text":117,"@type":113},"It describes convergence of region-specific co-infections and host factors that impair viral clearance, promote chronic immune activation, and enable immune evasion, supporting malignant transformation.",{"name":119,"@type":110,"acceptedAnswer":120},"What tumor-associated immune mechanisms are highlighted as drivers of immunosuppression?",{"text":121,"@type":113},"The review emphasizes immunosuppressive microenvironments with impaired antigen presentation and dominance of immune checkpoint pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350738,1790794023,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nImmunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges  \nVictor Ayodele Aliyu 1, *, Olalekan Chris Akinsulie 2, Babatunde Ibrahim Olowu 2, Ibrahim Idris 3, Favour Akinfemi Ajibade 4, Pius I. Babawale 5, Oluwawemimo Adebowale 6, Charles Egede Ugwu 7, Chizaram Blessing Ukauwa 8, Onyedikachi Emmanuel Itumo 9, Peter Arinze Oge 10, Sammuel Shahzad 2, Chizobam Lilian Chukwu 11, Toyin Florence Ayandokun 12, Joy Taiye Aliyu 13, Peace Kehinde Aliyu 13, Jesuferanmi Mary Akinsulie 14, Muhammad Ipoola Adeyemi 15 and Olamilekan Gabriel Banwo 16  \nAcademic Editor: Robbie B. Mailliard  \nReceived: 13 June 2026  \nRevised: 16 July 2026  \nAccepted: 24 July 2026  \nPublished: 28 July 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA  \n2 Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA; [olalekan.akinsulie@wsu.edu](olalekan.akinsulie@wsu.edu) (O.C.A.)  \n3 School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA  \n4 Department of Microbiology and Molecular Genetics, The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405, USA  \n5 Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Barton Rouge, LA 70803, USA  \n6 Department of Veterinary Public Health and Preventive Medicine, College of Veterinary Medicine, Federal University of Agriculture Abeokuta, Abeokuta 110124, Ogun State, Nigeria  \n7 Paul G. Allen School for Global Health, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA  \n8 Department of Animal Health and Production, Faculty of Veterinary Medicine, University of Abuja, FCT, Abuja 900102, Nigeria  \n9 Department of Public Health, Middlesex University London, London NW4 4BT, UK  \n10 Department of Human Anatomy, University of Cross Rivers State, Yala 550107, Cross Rivers State, Nigeria  \n11 Department of Medical Microbiology, Imo State University, Owerri 460222, Imo State, Nigeria  \n12 Department of Chemistry, College of Arts and Sciences, Washington State University, Pullman, WA 99164, USA  \n13 Department of Medicine and Surgery, Faculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife 220282, Osun State, Nigeria  \n14 School of Health Sciences and Society, University of Suffolk, Ipswich IP3 0AQ, UK  \n15 Department of Biological Sciences, Faculty of Natural Science and Technology, University of Bergen, 5020 Bergen, Norway  \n16 Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Ibadan 200132, Oyo State, Nigeria  \n* [Correspondence: victor.aliyu@wsu.edu](Correspondence: victor.aliyu@wsu.edu)  \nAbstract  \nOncogenic viruses contribute to approximately 20% of human cancers globally, with their impact falling disproportionately on populations in Sub-Saharan Africa. In this region, cervical cancer, hepatocellular carcinoma, endemic Burkitt lymphoma, and Kaposi sarcoma represent major causes of cancer-related morbidity and mortality, driven by persistent infection with human papillomavirus (HPV), hepatitis B and C viruses (HBV/HCV), Epstein–Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), and human T-lymphotropic virus-1 (HTLV-1) . This review synthesizes current insights into the immunological mechanisms that underpin viral carcinogenesis in Africa, emphasizing how defective viral clearance, chronic immune activation, and immune evasion arise from the convergence of region-specific co-infections, host genetic diversity, and environmental exposures. We examine the mechanistic roles of HIV-associated CD4+ T cell deplet","cbCaieLEkE3vOIcP","https://ap.wps.com/l/cbCaieLEkE3vOIcP","pdf",2812832,49,"English","# Abstract\n# Keywords\n# 1. Introduction to the Global Landscape of Viral Carcinogenesis and Disproportionate Cancer Burden in Africa","[{\"question\":\"Which oncogenic viruses are emphasized in the review’s scope for Africa-related cancers?\",\"answer\":\"The review focuses on HPV, HBV, HCV, EBV, KSHV, and HTLV-1 as key oncogenic viruses contributing to cancer burden in Sub-Saharan Africa.\"},{\"question\":\"How do co-infections and immune interactions contribute to viral persistence and cancer development?\",\"answer\":\"It describes convergence of region-specific co-infections and host factors that impair viral clearance, promote chronic immune activation, and enable immune evasion, supporting malignant transformation.\"},{\"question\":\"What tumor-associated immune mechanisms are highlighted as drivers of immunosuppression?\",\"answer\":\"The review emphasizes immunosuppressive microenvironments with impaired antigen presentation and dominance of immune checkpoint pathways.\"}]","Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa - Mechanisms, Co-Infections and Public Health Challenges | PDF",1790090830,123,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ed5118fc43ce6899a130b5d47c150f6.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c4d68d74f78ce15aaa9eb5cc498b14.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61967579af809388a0691b82c83f9091.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b78263dbd10b0b78b2a307faeb4cccd.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dafe2edad125d2c60224f51a39ce22ca.webp",979,1384]